Research Paper Volume 14, Issue 13 pp 5427—5448
Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer
Figure 8. The SDC1 expression features in BC samples. (A) The IHC assay showed the SDC1 expression level in the high-risk and low-risk patients. (B) The IF assay verified the SDC1 and CD206 expression levels, as well as their co-expression in the high-risk and low-risk patients. CD206, green; SDC1, red; DAPI, nucleus.